Annals of Emergency Medicine 2019;73:237-247
Samuels, Elizabeth A. | D'Onofrio, Gail | Huntley, Kristen | Levin, Scott | Schuur, Jeremiah D. | Bart, Gavin | Hawk, Kathryn | Tai, Betty | Campbell, Cynthia I. | Venkatesh, Arjun K.
Emergency clinicians are on the front lines of responding to the opioid epidemic and are leading innovations to reduce opioid overdose deaths through safer prescribing, harm reduction, and improved linkage to outpatient treatment. Currently, there are no nationally recognized quality measures or best practices to guide emergency department quality improvement efforts, implementation science researchers, or policymakers seeking to reduce opioid-associated morbidity and mortality. To address this gap, in May 2017, the National Institute on Drug Abuse's Center for the Clinical Trials Network convened experts in quality measurement from the American College of Emergency Physicians' (ACEP's) Clinical Emergency Data Registry, researchers in emergency and addiction medicine, and representatives from federal agencies, including the National Institute on Drug Abuse and the Centers for Medicare & Medicaid Services. Drawing from discussions at this meeting and with experts in opioid use disorder treatment and quality measure development, we developed a multistakeholder quality improvement framework with specific structural, process, and outcome measures to guide an emergency medicine agenda for opioid use disorder policy, research, and clinical quality improvement.
Keywords: Emergency departments | Heroin | Pharmacological therapy | Prescription-type opiates | Quality improvement (QI) | Annals of Emergency Medicine (journal)
Document No: 1353 ; PMID: 30318376 ; PMCID: PMC6817947
Submitted by: CTN Dissemination Librarians (5/9/2019)
